Endoscopy is a safe and effective modality for the diagnosis and treatment of lesions in the gastrointestinal (GI) tract. During the last few decades, improvements in image quality and technical advances have led to the widespread use of endoscopy in various medical fields. Because it is relatively noninvasive and generally safe, the role of endoscopy has been emphasized in morbid patients with postoperative GI bleeding. However, there has been concern about the safety and complications of endoscopy. Here, we review endoscopic management of GI bleeding as a complication of surgery and therapeutic endoscopy.
Introduction
Endoscopic resection such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) can be used to treat various gastrointestinal (GI) tract neoplasms including premalignant and malignant lesions of the esophagus, stomach, duodenum, and colorectum. 1 However, postprocedural bleeding or perforation are uncommon complications of endoscopic treatment and can be fatal. Fortunately, most iatrogenic complications such as post EMR or ESD bleeding can be controlled by endoscopic interventions. 2 Moreover, endoscopic modalities can be used to treat postoperative complications such as GI bleeding, anastomosis leakage, and perforation and prevent unnecessary reoperations. 3 Endoscopy enables identification of the bleeding focus and management of GI bleeding. Hemostasis of suture-line bleeding can be achieved using various endoscopic modalities (e.g., injection, mechanical, and thermal therapy). 4 In this article, we review the endoscopic management of procedure-related and postoperative hemorrhage.
Procedure Related Bleeding in the GI Tract
Procedural bleeding of the stomach Endoscopic resection is minimally invasive and as effective as surgery for early gastric cancer. 5 Technical advances have led to the widespread use of ESD as a first-line therapy for early gastric cancer without evidence of metastasis. 6 ESD is associated with higher rates of en bloc and R0 resection than EMR, and a lower rate of local recurrence. [7] [8] [9] Despite the larger areas of resection, the rate of postprocedural bleeding after ESD is comparable to that after EMR according to recent meta-analyses. 7, 10 Post ESD bleeding is the most frequent adverse event associated with ESD. 11 The incidence of bleeding after gastric ESD is 0.6% to 15.6%, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] and the overall incidence of postprocedural bleeding is 5.1%. 27 The risk of bleeding after ESD is higher in the stomach compared to other sites. 11 Most instances of post ESD bleeding occurred within 24 hours of ESD, but in some cases occurred up to 4 weeks later. 19, 24 Comorbidities, lesion size (≥ 4 cm), antithrombotic therapy, lesion location (lesser curvature, upper stomach), and a prolonged procedure are risk factors of delayed bleeding after gastric ESD. 12, 13, 27, 28 Intraprocedural bleeding is more frequent in the mid and up-per stomach due to the greater diameter of submucosal arteries compared to the lower stomach. Delayed bleeding is thought to be more frequent in lesions in the lower stomach, likely due to antral peristalsis, bile reflux, and more careful hemostasis in lesions in the upper or mid-stomach. 15, 19, 20 However, in a recent meta-analysis, the overall bleeding rate did not significantly differ according to lesion location, but delayed bleeding was associated with lesions in the upper stomach. 27 Further studies are required for this issue.
Prophylactic management of postprocedural bleeding
Anti-acid therapy can reduce the rate of postprocedural bleeding after EMR. 29 In a meta-analysis of five studies involving 506 patients, the rate of delayed bleeding was reduced in patients treated with a proton pump inhibitor compared to an H 2 receptor antagonist (H2RA) (odds ratio [OR], 0.41; 95% confidence interval [CI], 0.20-0.85). Regarding EMR, there were no significant differences in the rate of delayed bleeding between the two groups. 30 Muco-protective agents may enhance artificial ulcer healing after gastric ESD. However, the rate of delayed bleeding was not reduced by faster ulcer healing in several randomized controlled trials (RCTs) and a meta-analysis 27, [31] [32] [33] Routine secondlook endoscopy after ESD remains controversial. [34] [35] [36] [37] However, in the meta-analysis of three RCTs involving 854 patients, secondlook endoscopy had no advantage for the prevention of post ESD bleeding. 38 Moreover, in a recent meta-analysis of 12 nonrandomized studies, second-look endoscopy had no effect in reducing delayed post ESD bleeding. 39 However, the role of secondlook endoscopy is unclear in high-risk patients according to the Forrest classification. 24, 35, 40 Endoscopic management of procedural bleeding Intraprocedural bleeding is a common complication during ESD that necessitates repeated hemostasis. Identification of vessels during submucosal dissection and prophylactic hemostasis is important to prevent intraprocedural bleeding (Fig. 1) . Prophylactic coagulation and minor oozing from small vessels can be managed with dissection knives; hemostatic forceps are useful for controlling active arterial bleeding. 19, [41] [42] [43] If coagulation forceps fail to control bleeding before hemoclip application, the bleeding site must be fully exposed. 1 Because their use can hinder further dissection, hemoclips should be reserved for uncontrolled bleeding or after completion of dissection. 44 After dissection, routine coagulation of all visible vessels should be performed to reduce the risk of delayed bleeding. 19 In most cases, delayed bleeding can be managed using standard endoscopic hemostasis methods (Table 1) . [12] [13] [14] [16] [17] [18] [19] [20] 23, 24 The degree of ulcer healing might affect the treatment decision. Hemoclips or coagulation forceps are useful in the early phase of ulcer healing (Fig. 2) , whereas injection therapy can be useful in the late phase due to hardening of the ulcer floor over time. 45 Procedural bleeding of the colon Globally, colorectal cancer is the third most common cancer. cidence of colorectal cancer and the rate of cancer-related mortality. [47] [48] [49] Endoscopic treatment is now used widely, although there is some concern over complications, including bleeding (the most frequent complication) and perforation. Postprocedural bleeding is potentially life threatening 50 and can require hospitalization, repeated colonoscopy, and blood transfusion. 51 The incidence of postprocedural bleeding in the colon is 0.6% to 8.1%. [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] Postprocedural bleeding can occur immediately or be delayed by up to 2 to 4 weeks. 64, 65 The risk of bleeding is higher in patients with comorbidities (cardiovascular disease or hypertension), large polyps (> 10 mm), polyps located in the right colon, and polyps with a large stalk (≥ 5 mm). 66, 67 Antiplatelet or anticoagulant therapy is reportedly associated with delayed bleeding. 56, 68 The rate of delayed bleeding is estimated to increase by 13% for each 1 mm increase in polyp diameter. 69 However, despite the larger polyp size, the bleeding risk for ESD is comparable to EMR according to a recent meta-analysis. 70 Prophylactic management of postprocedural bleeding Although prophylactic clipping after polypectomy has been used to reduce the rate of delayed bleeding, the evidence for the efficacy of this practice is weak, particularly for small polyps. A recent RCT of 3,365 polyps of < 2 cm demonstrated no decrease in bleeding in patients with compared to those without prophylactic clips. 71 Moreover, in a recent network meta-analysis, the rate of delayed bleeding was not reduced by prophylactic injection, mechanical, or coagulation therapy, but the risk of early postpolypectomy bleeding was reduced by mechanical or injection ther- apy. 72 However, in two RCTs involving large polyps (≥ 2 cm), mechanical prophylaxis such as a detachable snare or hemoclips in combination with adrenaline injection reduced the rate of delayed bleeding compared to adrenaline injection alone. 73, 74 Prophylactic epinephrine injection might be useful for large pedunculated polyps. 75 Clip closure is a feasible alternative, which is reportedly associated with a decreased frequency of delayed bleeding (1.8% for ≥ 2 cm and 1.1% for 1-4 cm polyps) compared to no-closure (9.7% for ≥ 2 cm and 6.9% for 1-4 cm polyps). 76, 77 This is in agreement with a report that clip closure of ESD-induced mucosal defects reduces the risk of delayed bleeding (0% vs 8.2%; P = 0.008). 78 Endoscopic management of procedural bleeding
In cases of intraprocedural bleeding after polypectomy, hemostasis can be achieved by snare-tip soft coagulation or using coagulation forceps or hemoclips. 79, 80 Snare-tip soft coagulation achieved effective hemostasis in 91% of intraprocedural bleeding patients. Additional treatment with coagulating forceps is required if hemostasis is not achieved using the snare-tip alone. Hemoclips are not used during the procedure as they could interfere with further resection. 79, 81 Intraprocedural bleeding after removal of a pedunculated polyp can be managed using hemoclips. Grasping the remaining stalk with the snare is a feasible method to stop bleeding; maintain a clear visual field; and provide time for the application of clips, an injection needle, or hemostatic forceps. 44 If intraprocedural bleeding is refractory to conventional modalities, the over-the-scope clip (OTSC) can be used; OTSC showed a 100% success rate for procedure-related bleeding after polypectomy, EMR, or ESD in the colon. [82] [83] [84] [85] [86] The main disadvantage of OTSC is the need for withdrawal of the endoscope to load the device. 1 Delayed bleeding is usually caused by ulceration at the polypectomy site, 87 and can in most cases be resolved by standard endoscopic treatment (Table 2) . [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] Hemostasis with clips is preferred to avoid further thermal injury to the muscle layer (Fig. 3) . 1 Caution should be taken when using thermal therapy in the right colon because of coagulation syndrome and perforation. 88 
Procedural bleeding of the esophagus
Endoscopic therapy is an established treatment modality for early esophageal squamous cell carcinoma and Barrett's neoplasm. 89 The mortality rate of patients with early esophageal cancer after endoscopic resection is comparable to that after surgery. 90 Endoscopic resection is primarily indicated for lesions confined to the mucosal layer classified as M1 (epithelium) or M2 (lamina propria), because such lesions rarely show lymph node invasion. 89 ESD is preferred over EMR due to its better en bloc and curative resection rates. 91 The frequency of procedure-related bleeding after ESD is reportedly 0% to 22.8%, and the overall incidence is 2.5%. 1 The frequency of postprocedural bleeding is higher after ESD than EMR. However, in a recent meta-analysis of six studies involving 864 superficial esophageal cancers, there were no significant differences in the rate of postprocedural bleeding between the ESD and EMR groups (OR, 0.74; 95% CI, 0.20-2.74), with no heterogeneity (I 2 = 0%). 92 Bleeding can generally be managed using standard hemostatic techniques. 93 Endoscopic hemostasis is effective for the control of postprocedural bleeding after esophageal ESD. In a recent meta-analysis of 11 studies involving 524 patients with early Barrett's neoplasia, the pooled estimate for bleeding after ESD was 1.7% (95% CI, 0.6-3.4), and all cases of bleeding were successfully managed using endoscopic modalities. 94 
Postoperative Bleeding Complication
Surgical treatment is an essential part for the management of disease. And increasing demand for digestive surgery is estimated. Because the global incidence of digestive cancer has been increased, largely due to the population aging and population growth. 95 Moreover, the number of bariatric operations performed globally is increasing due to the increasing prevalence of obesity. 96, 97 Although postoperative bleeding is an uncommon complication and mostly self-limiting, complications from surgery should not be ignored 98 considering the increasing burden of digestive surgery. 95 Moreovcer, postoperative bleeding can prolong hospital stay and result in morbidity and mortality, particularly in critically ill patients. [99] [100] [101] Postoperative bleeding can be intraluminal or extraluminal. Indeed, a significant proportion of hemorrhage is extraluminal [102] [103] [104] [105] and combined intra/extra-luminal bleeding is not uncommon. [106] [107] [108] [109] Intraluminal GI bleeding can be caused by a ruptured pseudoaneurysm secondary to an anastomotic leak after pancreaticoduodenectomy. Endoscopy is a reliable modality for the management of intraluminal GI bleeding. However, in case of bleeding involving extraluminal component, endoscopy can fail to detect the exact site and amount of hemorrhage delaying the appropriate intervention such as angiographic embolization or surgery. 109, 110 Making decisions regarding treatment for postoperative bleeding is complicated and should take into consideration the type of surgery, accessibility of the bleeding site, time after surgery, and comorbidities. 110 Because postoperative bleeding is associated with significant morbidity and mortality, the risks and benefits of therapeutic interventions, including conservative modalities, should be considered. 4 
Postoperative GI Bleeding after GI Surgery
Postoperative GI bleeding can be caused by surgery itself or a surgery-related condition (Fig. 4) . Marginal ulcers may develop from mucosal ischemia originating from perfusion defects, anastomosis tension, or sutures material. 111 Although bleeding from suture line is a major source of intraluminal GI bleeding, 112 stressrelated mucosal damage can cause upper GI bleeding. 4 Gastritis, duodenitis, gastric ulcer, and duodenal ulcer can be caused by colorectal or non-GI surgery such as cardiothoracic or vascular surgery. 4, 99, 113 Mallory-Weiss tear can be caused by postoperative nausea and vomiting. 114, 115 Importantly, comorbidities are closely related to the risk of postoperative bleeding. The number of postoperative complications is associated with the number of comorbidities in a study of gastric cancer patient. 116 The incidence of postoperative bleeding varies from 0.22% to 8.4% according to the type of surgery and the definition used. 98, 102, [104] [105] [106] [107] [108] [109] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] The presentation of postoperative bleeding varies according to its site and extent, from an asymptomatic decrease in hemoglobin level to overt signs of hemorrhage and hemodynamic instability. Hematemesis is a common clinical presentation after GI surgery. Hematemesis was reported in 73% of patients with GI bleeding in a retrospective study involving 933 patients who underwent Roux-en-Y gastric bypass (RYGB) surgery. The frequent hematemesis may be related to the small gastric pouch with a limited gastric reservoir. 117 In the literature, endoscopic treatment was performed in 4.5% to 100% of patients with intraluminal GI bleeding and has a success rate of 20% to 100% (Table 3) . 98 The success rate of endoscopic treatment is related to the type of surgery. The different accessibility to the bleeding focus is a main reason for this (Fig. 5) . Endoscopic treatment is relatively difficult for RYGB or pancreaticoduodenectomy compared to gastrectomy or colectomy. 106, 107, 109, 118, 119 The hemostasis success rate after gastrojejunostomy is favorable. 117, 118, 126 Moreover, a bleeding focus in the anastomotic ring may be associated with the success of hemostasis. In a retrospective study of 16,591 patients who had undergone gastrectomy, the hemostasis success rate was highest on the anterior wall (100%) and lowest on the posterior wall (50%) of the anastomotic ring. 120 Therefore, easy accessibility with a right angle is crucial part for successful hemostasis.
Endoscopic Treatment of Postoperative GI Bleeding
Endoscopy for postoperative GI bleeding enables identification of the bleeding site, treatment of the bleeding, and estimation of the risk of rebleeding. 114 Although there was concern about a risk of anastomotic disruption and perforation during endoscopic procedures performed immediately after surgery, 129 endoscopy was reported to be safe without significant complications even in the early postoperative period in recent studies. In a randomized controlled study of patients with recurrent ulcer bleeding, the success rates of endoscopic and surgical treatment were not significantly different, and complications were less common after endoscopic treatment. 131 Endoscopic hemostasis should initially be attempted for postoperative intraluminal hemorrhage. The hemostatic technique for postoperative bleeding does not different from that of conventional GI bleeding (Fig. 6) . Clipping, epinephrine injection, electrocoagulation, and argon plasma coagulation are the available options for hemostasis. 114 Hemoclips are more durable for anastomotic bleeding and do not injure tissue, unlike sclerosant injection or electrocoagulation, and can be used to manage anastomotic leaks or iatrogenic perforations. 132 However, hemoclips application can be technically difficult due to a poor axis caused by anatomical distortion after surgery. No RCT has compared the therapeutic efficacies of the various modalities for postoperative hemorrhage. However, Lee et al 112 reported that the rate of rebleeding was significantly higher after epinephrine and/or heater probe coagulation than after hemoclip application (33% vs 5%). In cases of diffuse bleeding in which hemostasis is not achieved by conventional modalities, hemospray can be used in the early postoperative period. 133 For the refractory bleeding, the OTSC has an acceptable success rate. 134 
Surgery-Specific Considerations Bariatric surgery
Sleeve gastrectomy is the most commonly performed procedure worldwide (45.9%), followed by RYGB (39.6%). 96 Bleeding can arise from multiple sites (e.g., anastomoses, staple lines, the pouch, the contiguous small intestine, the excluded stomach, or the bypassed small intestine). 135 Early bleeding usually occurs at the staple lines of the gastrojejunal anastomosis and has an incidence of 1% to 5% after RYGB and 0% to 8% after sleeve gastrectomy. Late bleeding is usually secondary to an anastomotic ulcer. Upper endoscopy can be performed to access the gastrojejunal anastomosis. 136 However, the diagnosis can be particularly difficult when the source of the bleeding is in the bypassed gastric remnant, proximal duodenum, or biliopancreatic limb. 123 Excluded GI segments after Roux-en-Y reconstruction can be accessed using double-balloon enteroscopy. 135 Alternatively, laparoscopic-or laparotomy-assisted endoscopy can be performed. 137 Bleeding at the gastrojejunal anastomosis can be treated endoscopically in conjunction with standard hemostatic modalities (epinephrine injection, thermal therapy, and hemoclipping). Hemoclipping is A B the preferred method, and use of thermal therapy at the staple line and anastomosis site requires caution due to the risk of tissue injury. 136 
Pancreaticoduodenectomy
Pancreaticoduodenectomy is a complex, high-risk surgery for tumors of the pancreatic head and other periampullary structures. The incidence of postpancreaticoduodenectomy hemorrhage is 2.5% to 20.2%, 106 and the incidence of postoperative intraluminal GI bleeding is 2.2% to 8.4%. [105] [106] [107] [108] [109] Standard pancreaticoduodenectomy involves distal gastrectomy, duodenectomy, partial pancreatectomy, partial choledochectomy, cholecystectomy, and proximal jejunectomy. Therefore, the procedure involves three anastomoses (gastrojejunostomy, hepaticojejunostomy, and pancreaticojejunostomy). Pylorus-preserving pancreaticoduodenectomy preserves the stomach, pylorus, and the proximal duodenum, which is anastomosed to the jejunum. 138 Bleeding can occur at the gastrojejunostomy, hepaticojejunostomy, pancreaticojejunostomy, and/or duodenojejunostomy suture line. In cases of suspected GI bleeding, endoscopy is used to identify the bleeding site and achieve hemostasis. However, the success rate of endoscopic treatment after pancreatoduodenectomy is less than 60%, 106 ,107,109 possibly due to interference by blood clots in the stomach and because of difficulty accessing the pancreaticojejunostomy suture line if the field of view is obscured by active bleeding. 139 
Conclusion
Postoperative and procedure-related bleeding are uncommon complications, but can prolong the hospital stay and result in significant morbidity and mortality. Endoscopic modalities are firstline options for surgery-or procedure-related GI bleeding as they enable localization and the control of bleeding. However, data on the efficacy of the available treatment modalities are insufficient. Moreover, the efficacy of these modalities is affected by the postoperative anatomy and bleeding location. Treatment decisions should take into consideration, among other factors, the type of surgery or endoscopic procedure. Hemostasis can be achieved using various endoscopic modalities, which have acceptable success rate and safety profiles.
Conflicts of Interest
No potential conflict of interest relevant to this article was reported. 
